主权项 |
1. Oral dosage form for modified release containing
a) particulate, crystalline apixaban and b) matrix former, wherein preferably the apixaban particle size distribution has a D50-value of 5 to 500 μm, and wherein the matrix former is selected from cellulose ether, cellulose ester, starch, gum, shellac, fatty substances, polyvinylchloride, polyvinyl alcohol polyvinyl acetate or copolymers thereof, polymers based on acrylic acid and/or methacrylic acid and ionic exchange resins. |